“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Research Abstracts

Research Abstracts

Abstract

10.1177/1076167503258357 OTHER Research AbstractsResearch RESEARCH ABSTRACTS A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9. Age-Related Eye Disease Study Report. (2001). Archives of Clinical Ophthalmology, 119(10), 1439-1452. To evaluate the effect of a high-dose antioxidant formulation on the development and pro- gression of age-related lens opacities and visual acuity loss, a clinical trial was conducted at 11 centers. Fifty-six percent of the participants were female, 96% were White, and the median age was 68 years. Participants were randomly assigned to receive daily oral tablets containing either antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; and beta carotene, 15 mg) or no antioxidants. Participants with more than a few small drusen were also ran- domly assigned to receive tablets with or without zinc (80 mg or zinc as zinc oxide) and copper (2 mg of copper as cupric oxide) as part of the age-related macular degeneration (AMD) trial. Baseline and annual (starting at year 2) lens photographs were graded at a reading center for the severity of lens opacity using the Age-Related Eye Disease Study (AREDS) cataract grading scale. About 2.3%
Loading next page...
Problems Reading this Article? Report Issue Here
 
/lp/sage/research-abstracts-Xb3ooUGjsW

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for only $40/month.

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.